Nose-associated lymphoid tissue (NALT) in the rodent upper respiratory tract develops postnatally and is considered to be independent of several factors known to be involved in the organogenesis of LN and Peyer's patches (PP). In this study we demonstrate that at least two different pathways result in NALT development. Following NALT anlage formation the intrinsic pathway relies on a signaling cascade including those mediated through the chemokine receptor CXCR5 and the lymphotoxin beta receptor (LTbetaR). This allows for the formation of high endothelial venules and thereby the recruitment of lymphocytes into NALT. Alternatively, high endothelial venule formation and lymphocyte recruitment can be induced in the NALT anlage by environmental signals, which are independent of LT-betaR and chemokine receptor CXCR5 signaling but in part rely on CD40 ligand. Thus, our study identifies a novel mechanism that facilitates the rescue of NALT development at late stages in adult life independent of the canonical LTbetaR-CXCR5 signaling axis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/eji.200939422 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ontogeny of the organized nasopharynx-associated lymphoid tissue in rainbow trout.
Dev Comp Immunol
January 2025
Center for Evolutionary and Theoretical Immunology, Department of Biology, University of New Mexico, Albuquerque, NM, 87131, USA. Electronic address:
Understanding the ontogeny of teleost mucosa-associated lymphoid tissues (MALT) is critical for determining the earliest timepoint for effective mucosal vaccination of young fish. Here, we describe the developmental sequence that leads to the formation of an organized MALT structure in rainbow trout, the organized nasopharynx-associated lymphoid tissue (O-NALT). Control rainbow trout were sampled between 340 and 1860 degree days (DD) and routine histology and immunofluorescence staining were used to determine cellular changes in immune cells in the nasal cavity as well as O-NALT formation.
View Article and Find Full Text PDFIntranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model.
Vaccines (Basel)
October 2024
Instituto de Inmunología Clínica y Experimental de Rosario (IDICER-CONICET), Rosario 2000, Argentina.
Article Synopsis
- Chagas disease, caused by a parasite, affects about 30% of infected individuals, leading to severe heart complications, and currently has no available vaccine for prevention.
- This study tested a mucosal vaccine candidate (TS+A) by administering it nasally, which resulted in immune responses and reduced inflammation and parasite levels in infected mice.
- The TS+A vaccine demonstrated effectiveness not only in the acute phase of the disease but also helped in minimizing chronic heart complications associated with Chagas disease.
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.
Front Immunol
September 2024
Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN, United States.
Mucosal barrier tissues and their mucosal associated lymphoid tissues (MALT) are attractive targets for vaccines and immunotherapies due to their roles in both priming and regulating adaptive immune responses. The upper and lower respiratory mucosae, in particular, possess unique properties: a vast surface area responsible for frontline protection against inhaled pathogens but also simultaneous tight regulation of homeostasis against a continuous backdrop of non-pathogenic antigen exposure. Within the upper and lower respiratory tract, the nasal and bronchial associated lymphoid tissues (NALT and BALT, respectively) are key sites where antigen-specific immune responses are orchestrated against inhaled antigens, serving as critical training grounds for adaptive immunity.
View Article and Find Full Text PDFMucosal immunity in upper and lower respiratory tract to MERS-CoV.
Front Immunol
September 2024
Academic and Research Departments, Section of Immunology, School of Biosciences, University of Surrey, Surrey, United Kingdom.
Article Synopsis
- - MERS-CoV, with a high mortality rate, causes severe respiratory illness, highlighting the urgent need for effective therapeutic vaccines against the virus.
- - This review analyzes immune responses in the upper and lower respiratory tracts to MERS-CoV, focusing on key players such as macrophages, T cells, and B cells that produce antiviral substances to combat infection.
- - While innate and adaptive immune systems show potential to control MERS-CoV, research on human mucosal immune responses is limited due to the lack of relevant tissue studies, indicating a need for deeper investigation.
Injectable Hydrogel Mucosal Vaccine Elicits Protective Immunity against Respiratory Viruses.
ACS Nano
April 2024
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, New Cornerstone Science Laboratory, National Center for Nanoscience and Technology of China, Beijing 100190, People's Republic of China.
Intranasal vaccines, eliciting mucosal immune responses, can prevent early invasion, replication, and transmission of pathogens in the respiratory tract. However, the effective delivery of antigens through the nasal barrier and boosting of a robust systematic and mucosal immune remain challenges in intranasal vaccine development. Here, we describe an intranasally administered self-healing hydrogel vaccine with a reversible strain-dependent sol-gel transition by precisely modulating the self-assembly processes between the natural drug rhein and aluminum ions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!